IBDEI3EF ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,57149,1,4,0)
 ;;=4^I83.218
 ;;^UTILITY(U,$J,358.3,57149,2)
 ;;=^5008002
 ;;^UTILITY(U,$J,358.3,57150,0)
 ;;=I83.221^^264^2849^152
 ;;^UTILITY(U,$J,358.3,57150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57150,1,3,0)
 ;;=3^Varic Veins Lt LE w/ Ulc of Thigh & Inflam
 ;;^UTILITY(U,$J,358.3,57150,1,4,0)
 ;;=4^I83.221
 ;;^UTILITY(U,$J,358.3,57150,2)
 ;;=^5008004
 ;;^UTILITY(U,$J,358.3,57151,0)
 ;;=I83.222^^264^2849^144
 ;;^UTILITY(U,$J,358.3,57151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57151,1,3,0)
 ;;=3^Varic Veins Lt LE w/ Ulc of Calf & Inflam
 ;;^UTILITY(U,$J,358.3,57151,1,4,0)
 ;;=4^I83.222
 ;;^UTILITY(U,$J,358.3,57151,2)
 ;;=^5008005
 ;;^UTILITY(U,$J,358.3,57152,0)
 ;;=I83.223^^264^2849^142
 ;;^UTILITY(U,$J,358.3,57152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57152,1,3,0)
 ;;=3^Varic Veins Lt LE w/ Ulc of Ankle & Inflam
 ;;^UTILITY(U,$J,358.3,57152,1,4,0)
 ;;=4^I83.223
 ;;^UTILITY(U,$J,358.3,57152,2)
 ;;=^5008006
 ;;^UTILITY(U,$J,358.3,57153,0)
 ;;=I83.224^^264^2849^146
 ;;^UTILITY(U,$J,358.3,57153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57153,1,3,0)
 ;;=3^Varic Veins Lt LE w/ Ulc of Heel/Midfoot & Inflam
 ;;^UTILITY(U,$J,358.3,57153,1,4,0)
 ;;=4^I83.224
 ;;^UTILITY(U,$J,358.3,57153,2)
 ;;=^5008007
 ;;^UTILITY(U,$J,358.3,57154,0)
 ;;=I83.225^^264^2849^150
 ;;^UTILITY(U,$J,358.3,57154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57154,1,3,0)
 ;;=3^Varic Veins Lt LE w/ Ulc of Oth Part of Ft & Inflam
 ;;^UTILITY(U,$J,358.3,57154,1,4,0)
 ;;=4^I83.225
 ;;^UTILITY(U,$J,358.3,57154,2)
 ;;=^5008008
 ;;^UTILITY(U,$J,358.3,57155,0)
 ;;=I83.228^^264^2849^147
 ;;^UTILITY(U,$J,358.3,57155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57155,1,3,0)
 ;;=3^Varic Veins Lt LE w/ Ulc of Oth Part LE & Inflam
 ;;^UTILITY(U,$J,358.3,57155,1,4,0)
 ;;=4^I83.228
 ;;^UTILITY(U,$J,358.3,57155,2)
 ;;=^5008009
 ;;^UTILITY(U,$J,358.3,57156,0)
 ;;=I83.91^^264^2849^41
 ;;^UTILITY(U,$J,358.3,57156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57156,1,3,0)
 ;;=3^Asymptomatic Varicose Veins Rt LE
 ;;^UTILITY(U,$J,358.3,57156,1,4,0)
 ;;=4^I83.91
 ;;^UTILITY(U,$J,358.3,57156,2)
 ;;=^5008020
 ;;^UTILITY(U,$J,358.3,57157,0)
 ;;=I83.92^^264^2849^40
 ;;^UTILITY(U,$J,358.3,57157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57157,1,3,0)
 ;;=3^Asymptomatic Varicose Veins Lt LE
 ;;^UTILITY(U,$J,358.3,57157,1,4,0)
 ;;=4^I83.92
 ;;^UTILITY(U,$J,358.3,57157,2)
 ;;=^5008021
 ;;^UTILITY(U,$J,358.3,57158,0)
 ;;=I83.93^^264^2849^39
 ;;^UTILITY(U,$J,358.3,57158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57158,1,3,0)
 ;;=3^Asymptomatic Varicose Veins Bil LE
 ;;^UTILITY(U,$J,358.3,57158,1,4,0)
 ;;=4^I83.93
 ;;^UTILITY(U,$J,358.3,57158,2)
 ;;=^5008022
 ;;^UTILITY(U,$J,358.3,57159,0)
 ;;=I89.0^^264^2849^111
 ;;^UTILITY(U,$J,358.3,57159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57159,1,3,0)
 ;;=3^Lymphedema NEC
 ;;^UTILITY(U,$J,358.3,57159,1,4,0)
 ;;=4^I89.0
 ;;^UTILITY(U,$J,358.3,57159,2)
 ;;=^5008073
 ;;^UTILITY(U,$J,358.3,57160,0)
 ;;=I87.2^^264^2849^163
 ;;^UTILITY(U,$J,358.3,57160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57160,1,3,0)
 ;;=3^Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,57160,1,4,0)
 ;;=4^I87.2
 ;;^UTILITY(U,$J,358.3,57160,2)
 ;;=^5008047
 ;;^UTILITY(U,$J,358.3,57161,0)
 ;;=K55.0^^264^2849^32
 ;;^UTILITY(U,$J,358.3,57161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57161,1,3,0)
 ;;=3^AC Intestine Vascular Disorders
 ;;^UTILITY(U,$J,358.3,57161,1,4,0)
 ;;=4^K55.0
 ;;^UTILITY(U,$J,358.3,57161,2)
 ;;=^5008705
 ;;^UTILITY(U,$J,358.3,57162,0)
 ;;=K55.1^^264^2849^69
 ;;^UTILITY(U,$J,358.3,57162,1,0)
 ;;=^358.31IA^4^2
